EVIDERA
Evidera, a leading global provider of evidence-based solutions, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 2014, the company has quickly established itself in the healthcare industry, specialising in health economics, outcomes research, and real-world evidence generation. Evidera's core offerings include innovative services that support pharmaceutical and biotechnology companies in demonstrating the value of their products. Their unique approach combines advanced analytics with deep therapeutic expertise, ensuring robust evidence generation that meets regulatory and market access needs. Recognised for its commitment to quality and scientific rigor, Evidera has achieved significant milestones, positioning itself as a trusted partner in the evolving landscape of health technology assessment and market access.
DitchCarbon Score
How does EVIDERA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EVIDERA's score of 94 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
EVIDERA, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with Thermo Fisher Scientific Inc., from which it inherits emissions data and climate commitments. EVIDERA's climate initiatives are aligned with those of Thermo Fisher Scientific Inc., which has established science-based targets (SBTi) and participates in various climate-related initiatives, including the Carbon Disclosure Project (CDP) and the RE100 initiative. These commitments reflect a broader industry trend towards transparency and accountability in carbon emissions management. As a current subsidiary of Thermo Fisher Scientific Inc., EVIDERA's climate strategy is influenced by the parent company's sustainability goals, although specific reduction targets or achievements for EVIDERA itself have not been disclosed. The cascading of climate commitments from Thermo Fisher Scientific Inc. ensures that EVIDERA is engaged in efforts to mitigate climate impact, although precise metrics and targets remain unspecified at this level. In summary, while EVIDERA does not provide its own emissions data, it is committed to climate action through its association with Thermo Fisher Scientific Inc., which sets a framework for sustainability and emissions reduction within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
EVIDERA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
